PLSE Pulse Biosciences Inc Quarterly Revenue Growth

Pulse Biosciences, Inc. (PLSE) - corporate logo

Pulse Biosciences, Inc. (PLSE) is developing nanosecond pulse oncology therapies, attracting top engineers through R&D freedom and stock options. Quarterly revenue dynamics visualize this potential, with the current level standing at 358.60. The company is currently implementing precision robotics for the accurate targeting of systems on tumor tissues and automating the calibration of its devices.

PLSE (Pulse Biosciences Inc) Quarterly Sales Growth Rate history from 07/04/2022 to 11/20/2026

Summary analytical data breakdowns for Pulse Biosciences Inc (PLSE)

- stock price and consensus target price:
Fundamental company valuation:Pulse Biosciences, Inc. - PLSE
Manufactured products of Pulse Biosciences

This indicator determines the dynamics of cash flow from operating activities by measuring the percentage change in revenue between consecutive quarters to assess business scaling rates. Analyzing the quarter-over-quarter change in sales volume makes it evident that for Pulse Biosciences, Inc. (PLSE), the absence of commercial turnover and the current clinical trial stage render this metric secondary, confirming that the stock's value currently depends on future technological catalysts.

Competing companies

DexCom Inc - Quarterly Revenue Growth|PEN (Penumbra, Inc.) - Sales Growth QoQ|NOVT: Quarterly Revenue Growth|HAE - Quarterly Sales Growth Rate|INSP (Inspire Medical Systems Inc) - Quarterly Revenue Growth|PROCEPT BioRobotics Inc (PRCT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth CNMD|Quarterly Sales Growth InMode Ltd. INMD|Revenue Growth QoQ Picard Medical PMI|Quarterly Revenue Growth Surmodics Inc SRDX|SENS - Revenue Growth QoQ|NPCE: Revenue Growth QoQ|TCMD (Tactile Systems Technology Inc.) - Quarterly Sales Growth|Sanuwave Health Inc - Quarterly Revenue Increase|Quarterly Sales Growth OM|Quarterly Revenue Growth Rate smartvest.com ELMD|Revenue Growth QoQ LENSAR Inc. (LNSR)|AVITA Medical, Inc. (RCEL) - Revenue Change vs Previous Quarter|Profound Medical Corp - Quarterly Sales Growth|Quarterly Revenue Growth Baird Medical Corp BDMD|EDAP TMS SA - Quarterly Revenue Growth|Quarterly Sales Growth Rate Apyx Medical Corporation APYX|IceCure Medical (ICCM) - Revenue Growth QoQ|Revenue Dynamics QoQ LUNG (Pulmonx Corp.)|Revenue Growth QoQ telabio.com|Quarterly Sales Growth Cytosorbents (CTSO)|Quarterly Revenue Growth SRTS|ZYXI - Quarterly Revenue Growth Rate|Revenue Growth QoQ electrocore.com ECOR|RBOT: Sales Growth QoQ|IINN: Quarterly Sales Growth|Quarterly Sales Growth Rate SeaStar Medical Holding ICU|IRIX: Quarterly Revenue Growth|INBS - Quarterly Sales Growth Rate|XAIR (Beyond Air Inc) - Quarterly Revenue Growth|PFSA: Quarterly Revenue Increase|Revenue Growth QoQ STRATA Skin Sciences Inc. (SSKN)|Quarterly Revenue Growth GlucoTrack, Inc. (GCTK)|Revenue Growth QoQ nanovibronix.com NAOV|Quarterly Revenue Growth Venus Concept Inc VERO|NUWE - Revenue Growth QoQ|AEMD: Revenue Growth QoQ|ASXC (Asensus Surgical) - Quarterly Sales Growth|Quarterly Revenue Growth Rate avinger.com (AVGR)|Quarterly Sales Growth BSGM|CUTR: Quarterly Revenue Increase|Revenue Growth QoQ Know Labs Corporation (KNW)|NARI - Quarterly Revenue Growth Rate|Revenue Growth QoQ Nevro Corp. NVRO|ReShape Lifesciences Inc - Revenue Growth QoQ|SILK: Quarterly Sales Growth